New cyclic FR-900520 microbial biotransformation agent

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing heterocyclic carbon compound having only o – n – s,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435170, C12P 1718, C12P 104

Patent

active

052906892

ABSTRACT:
Described is a process for producing a new immunosuppressant, a C-19/C-22 cyclic hemiketal (Compound I) biotransformation analog of FR-900520, under novel fermentation conditions utilizing the novel microorganism, Streptomyces sp. (Merck Culture Collection MA6969) ATCC No. 55280. The macrolide immunosuppressant is useful in preventing human host rejection of foreign organ transplants, e.g. bone marrow, liver, lung, kidney and heart transplants.

REFERENCES:
patent: 3244592 (1966-04-01), Arai
patent: 4081531 (1978-03-01), Arai
patent: 4242453 (1980-12-01), Umezawa et al.
patent: 4264607 (1981-04-01), Dewey et al.
patent: 4894344 (1990-01-01), Sugiyama et al.
patent: 5149701 (1992-09-01), Shafiee et al.
Hatanaka et al., The Journal of Antibiotics, XLI(11), 1592, (Nov. 1988).
Hatanaka et al., The Journal of Antibiotics, XLII(4), 620-622, (Apr. 1989).
Arai et al., J. Antibiotics, Ser. A, 15, (1962) pp. 231-232.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

New cyclic FR-900520 microbial biotransformation agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New cyclic FR-900520 microbial biotransformation agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New cyclic FR-900520 microbial biotransformation agent will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-576337

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.